NASDAQ:GENE
Genetic Technologies Limited
- Stock
market
STOCKSindustry
Diagnostics & Researchwebsite
www.gtglabs.comipo date
Jan 31, 1988
Genetic Technologies Limited, a molecular diagnostics company, provides predictive testing and assessment tools to help physicians manage women's health in Australia and the United States. The company's lead product is the BREVAGenplus, a clinically validated risk assessment test for non-hereditary breast cancer. It also markets BREVAGenplus to healthcare professionals in breas...Show More
Earnings
Earnings per Share (Estimate*)
Revenue (Estimate*)
*Estimate based on analyst consensus